Network-based drug repurposing for HPV-associated cervical cancer

Network-based drug repurposing for HPV-associated cervical cancer

In women, cervical cancer (CC) is the fourth most common cancer around the world with average cases of 604,000 and 342,000 deaths per year. Approximately 50% of high-grade CC are attributed to human papillomavirus (HPV) types 16 and 18. Chances of CC in HPV-positive patients are 6 times more than HP...

Full description

Bibliographic Details
Main Authors: Faheem Ahmed, Young Jin Yang, Anupama Samantasinghar, Young Woo Kim, Jeong Beom Ko, Kyung Hyun Choi
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Computational and Structural Biotechnology Journal
Subjects:
Cervical cancer
Drug repurposing
Human papillomavirus
Protein interactions
Systems biology
Online Access:http://www.sciencedirect.com/science/article/pii/S200103702300394X

Internet

http://www.sciencedirect.com/science/article/pii/S200103702300394X

Similar Items